#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=20.06.2023:
#Text=Status 2 uker post FESS.
1-1	0-10	20.06.2023	_	_	_	_	
1-2	10-11	:	_	_	_	_	
1-3	12-18	Status	_	_	_	_	
1-4	19-20	2	_	_	_	_	
1-5	21-25	uker	_	_	_	_	
1-6	26-30	post	_	_	_	_	
1-7	31-35	FESS	BEFOREOVERLAP	TREATMENT	_	_	
1-8	35-36	.	_	_	_	_	

#Text=God initial effekt.
2-1	37-40	God	_	_	_	_	
2-2	41-48	initial	_	_	_	_	
2-3	49-55	effekt	_	_	_	_	
2-4	55-56	.	_	_	_	_	

#Text=Mindre sekresjon, bedre luftpassasje.
3-1	57-63	Mindre	OVERLAP[1]	CONDITION[1]	_	_	
3-2	64-73	sekresjon	OVERLAP[1]	CONDITION[1]	_	_	
3-3	73-74	,	_	_	_	_	
3-4	75-80	bedre	OVERLAP[2]	CONDITION[2]	OVERLAP	3-1[1_2]	
3-5	81-93	luftpassasje	OVERLAP[2]	CONDITION[2]	_	_	
3-6	93-94	.	_	_	_	_	

#Text=Fortsetter Avamys.
4-1	95-105	Fortsetter	AFTER[3]	TREATMENT[3]	_	_	
4-2	106-112	Avamys	AFTER[3]	TREATMENT[3]	_	_	
4-3	112-113	.	_	_	_	_	

#Text=Saltvannskylling daglig.
5-1	114-130	Saltvannskylling	AFTER	TREATMENT	_	_	
5-2	131-137	daglig	_	_	_	_	
5-3	137-138	.	_	_	_	_	

#Text=Kontroll ØNH om 4 uker.
6-1	139-147	Kontroll	AFTER[4]	TREATMENT[4]	BEFORE|BEFORE	4-1[3_4]|5-1[0_4]	
6-2	148-151	ØNH	AFTER[4]	TREATMENT[4]	_	_	
6-3	152-154	om	_	_	_	_	
6-4	155-156	4	_	_	_	_	
6-5	157-161	uker	_	_	_	_	
6-6	161-162	.	_	_	_	_	
